Health Law & Managed Care

Healthcare is an area of law that is constantly evolving, with the Affordable Care Act provisions still rippling through the industry, and privacy and data protection concerns requiring constant vigilance, the National Law Review covers the latest developments in the Health Care Industry. The National Law Review offers analysis of news coming out of Congress related to health care legislation, as well as covering state and local laws related to health care.

Readers will also find an extensive list of cases, news, and up-to-date information on various topics in the healthcare and managed care sector. Litigation, regulatory actions being taken against doctors or pharmacies, mediation and arbitration, and coverage of the latest in drug pricing, the opioid epidemic,  employer-healthcare coverage options, and legal news about health and hospital systems and physician groups.

The National Law Review covers news related to Medicare and Medicaid, to CMS funding, changes to IPAs, PHO, HMO, MSO, and other entities. Readers will find information related to managed care, assisted living facilities, at-home care, and news/legislation from the Office of the Inspector General (OIG) and the Office of the Federal Contract Compliance Programs (OFCCP). Additionally, regulations and updates released by the FDA are covered, as well as changing state and federal regulations related to telehealth and telemedicine are also on the site. 

Cybersecurity in health care and compliance with HIPAA are major concerns for the industry.  Additionally, Ransomware developments and other data security breaches have required a greater emphasis on safeguarding patient-records and information. More compliance and restrictions are in place for doctors/hospitals sharing patient records, HIPPA regulations have become more stringent, and e-health records, have seen a number of changes in how hospitals and doctors’ offices, deal with patient-record management internally. The National Law Review offers expert legal analysis on changing regulations related to healthcare.

For hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law Twitter feed and sign up for daily complimentary e-news bulletins.

Custom text Title Organization
Nov
1
2023
IRS Announces 2024 Employee Benefit Plan Limits McDermott Will & Emery
Nov
1
2023
Hospital Mergers: The Value and Pitfalls Sheppard, Mullin, Richter & Hampton LLP
Nov
1
2023
The Increasing Trend of Chinese Asylum-Seekers at the US Border Norris McLaughlin P.A.
Nov
1
2023
OIG Issues Unfavorable Advisory Opinion on Free Items to Patients Tied to Reimbursable Services Mintz
Nov
1
2023
HHS Proposes Disincentives for Providers that Commit Information Blocking Robinson & Cole LLP
Nov
1
2023
White House Executive Order on Artificial Intelligence: Implications for the Health Care and Life Sciences Industries Epstein Becker & Green, P.C.
Oct
31
2023
Options for Menopause Benefits for Employees Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
31
2023
CMS Announces New Guide Model for People Living with Dementia and Their Caregivers McDermott Will & Emery
Oct
31
2023
Significant Changes to Massachusetts Paid Family Leave Coming on November 1, 2023 ArentFox Schiff LLP
Oct
31
2023
Safety Perspectives From Region 6: Tales and Lessons From the Field Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
31
2023
California Takes Steps Towards a Unified Health Care Financing System Squire Patton Boggs (US) LLP
Oct
31
2023
Top Takeaways | 2023 PPM-ASC Symposium | Specialty Spotlight: Behavioral Health McDermott Will & Emery
Oct
31
2023
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products Foley & Lardner LLP
Oct
31
2023
Massachusetts Department of Paid Family and Medical Leave Revises Guidance on Topping Off Benefits With Accrued Paid Leave Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
30
2023
Healthcare Preview for the Week of: October 30, 2023 McDermott Will & Emery
Oct
30
2023
Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules Mintz
Oct
30
2023
Don’t Leave Money on the Table from Your Pandemic-Era Healthcare Procurement Contract Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies ArentFox Schiff LLP
Oct
30
2023
District of Massachusetts Split on Causation Standard in Kickback FCA Cases Bradley Arant Boult Cummings LLP
Oct
30
2023
HRSA Confirms End of COVID Waiver of Advance Registration Requirement for Provider-Based Clinics Robinson & Cole LLP
Oct
30
2023
Telehealth Privacy and Security Risk Mitigation: Office for Civil Rights Provides Guidance to Providers, Patients Greenberg Traurig, LLP
Oct
30
2023
Lowest-Risk Clinical Trials Will Benefit from a New Notification Scheme and a Shorter Period for Application Processing McDermott Will & Emery
Oct
27
2023
AHLA Podcast: Anthony Burba Speaks on Clinical Decision Support Tools Barnes & Thornburg LLP
Oct
27
2023
Beltway Buzz, October 27, 2023 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
27
2023
SB 553 Workplace Violence Prevention: 12 Answers to Employers’ Frequently Asked Questions Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
27
2023
McDermottPlus Check-Up: October 27, 2023 McDermott Will & Emery
Oct
27
2023
CMS Seeks Stakeholder Feedback About Medicare Transaction Facilitator Services for the Medicare Drug Price Negotiation Program by November 13: Inflation Reduction Act Updates Epstein Becker & Green, P.C.
Oct
27
2023
HRSA Issues Notice Confirming 340B Registration Requirement McDermott Will & Emery
Oct
27
2023
Overcoming Safetyism & the Plaintiff Media Machine – Episode 66 [Video, Podcast] IMS Legal Strategies
Oct
27
2023
New York Adult Survivors Act Lookback Window Closes Soon Katz Banks Kumin LLP
Oct
27
2023
CCPA Amendments Extend Protections to Reproductive Health and Citizenship Status Sheppard, Mullin, Richter & Hampton LLP
Oct
27
2023
Trending in Telehealth: October 17 – 23, 2023 McDermott Will & Emery
Oct
27
2023
OIG To Pathology Lab: Don't Pay for Services you Don't Need McDermott Will & Emery
Oct
26
2023
HHS Office for Civil Rights Issues Resource for Providers to Educate Patients about Telehealth and Requirements Under HIPAA Barnes & Thornburg LLP
Oct
26
2023
Surge in Class Actions Under the Illinois Genetic Information Privacy Act von Briesen & Roper, s.c.
Oct
26
2023
FDA Issues New Warning Regarding Compounded Ketamine Foley & Lardner LLP
Oct
26
2023
A Name is Not Enough: Ninth Circuit Finds No Standing for First-to-File Shareholder to Appeal Securities Class Action Proskauer Rose LLP
Oct
26
2023
HHS-OIG Declines To Impose Sanctions On Physician Practice For Employed Physicians’ Bonus Compensation Structure Tied To ASC Facility Fee Profits Barnes & Thornburg LLP
Oct
25
2023
FCC Seeks Comment Regarding Role of Broadband Connectivity for Improving Maternal Health ArentFox Schiff LLP
Oct
25
2023
NM Talks Healthcare Podcast: Creating and Maintaining Privilege Over Internal Investigations [Podcast] Nelson Mullins
Oct
25
2023
DEA Further Extends Flexibilities for Controlled-Substance Prescribing Via Telemedicine McDermott Will & Emery
Oct
25
2023
Sanction Policies Can Help Drive Cybersecurity and HIPAA Compliance, OCR Says Jackson Lewis P.C.
Oct
24
2023
Digital Health 101: OCR Issues Resources to Educate Patients on Telehealth, PHI McDermott Will & Emery
Oct
24
2023
Policy Update to Foreign Residency Requirement for J-1 Exchange Visitors Greenberg Traurig, LLP
Oct
24
2023
Congress May Have a Vision for Psychedelic Regulation in the US Epstein Becker & Green, P.C.
Oct
24
2023
Dr. Jack of All Trades? OCR’s New Telehealth Guidance Suggests High Expectations on Providers Epstein Becker & Green, P.C.
Oct
24
2023
California Legislative Year-End Review: Preparing for 2024 (US) Squire Patton Boggs (US) LLP
Oct
24
2023
Stocking Naloxone in the Workplace: What Employers Need to Consider Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
24
2023
Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024 Mintz
Oct
24
2023
OHCA’s Revised Regulations Following Comments from Industry Stakeholders Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins